A spike-ferritin nanoparticle vaccine induces robust innate immune activity and drives polyfunctional SARS-CoV-2-specific T cells
J. M. Carmen, S. Shrivastava, Z. Lu, A. Anderson, E. B. Morrison, R. S. Sankhala, W.-H. Chen, W. C. Chang, J. Bolton, G. R. Matyas, N. L. Michael, M. G. Joyce, K. Modjarrad, J. R. Currier, E. Bergmann-Leitner, , M. Rao
This study evaluates a spike-ferritin nanoparticle vaccine with adjuvants, showing enhanced T cell responses and cross-reactivity against SARS-CoV and other coronaviruses.
bioRxiv · Apr 28, 2021 · PreprintImmunology